1. Home
  2. GSAT vs BMRN Comparison

GSAT vs BMRN Comparison

Compare GSAT & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globalstar Inc.

GSAT

Globalstar Inc.

SELL

Current Price

$83.13

Market Cap

10.7B

ML Signal

SELL

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

SELL

Current Price

$55.42

Market Cap

12.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GSAT
BMRN
Founded
2003
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
12.3B
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
GSAT
BMRN
Price
$83.13
$55.42
Analyst Decision
Buy
Buy
Analyst Count
3
27
Target Price
$90.00
★ $91.62
AVG Volume (30 Days)
558.6K
★ 2.1M
Earning Date
11-05-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 74.58
N/A
EPS
N/A
★ 0.77
Revenue
$112,660,000.00
★ $1,313,646,000.00
Revenue This Year
$8.42
$21.29
Revenue Next Year
$20.04
$14.48
P/E Ratio
★ N/A
$71.95
Revenue Growth
N/A
★ 17.62
52 Week Low
$40.50
$49.26
52 Week High
$84.85
$70.98

Technical Indicators

Market Signals
Indicator
GSAT
BMRN
Relative Strength Index (RSI) 53.20 26.85
Support Level $80.87 $55.28
Resistance Level $84.77 $57.95
Average True Range (ATR) 0.57 1.41
MACD 0.03 -0.53
Stochastic Oscillator 56.31 14.27

Price Performance

Historical Comparison
GSAT
BMRN

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: